Zacks.com on MSN
CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors
CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $54.21, signifying a -4.71% move from its prior day's close.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback